5A7-95352-53700
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 981 / WA
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-27
Registered in v-safe
-
2020-12-27
Dose 1 — Moderna
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-10
- 2021-01-17
-
2021-01-20
Dose 2 — Moderna
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site pruritus, Injection site reaction, Skin ulcer — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Spontaneous ulcerative lesion 1cm in diameter, approximately 4cm adjacent to injection site, with area of erythema surrounding it and pruritis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Injection site haemorrhage, Skin haemorrhage, Skin lesion — Feeling: Good · Site: Pain, Swelling · Rash, not including the immediate area around the injection siteFree text: Same lesion that I previously reported. It is unclear whether it is healing or not. It started bleeding when I removed the bandage this morning.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Injection site infection — Feeling: Good · Site: Pain, Swelling, ItchingFree text: Lesion next to the injection site is still open and oozing serous fluid. Slowly healing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pruritus, Injection site reaction, Scab, Skin lesion — Feeling: Good · Site: Pain, SwellingFree text: Erosive lesion adjacent to injection site. Now crusted, itching and healing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-03-31
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2021-04-21
- 2021-07-21
-
2022-01-21
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID-19 infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-24
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Moderna | |
| 2 | 2021-01-20 | Moderna |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Spontaneous ulcerative lesion 1cm in diameter, approximately 4cm adjacent to injection site, with area of erythema surrounding it and pruritis.
Systemic reaction (other): Same lesion that I previously reported. It is unclear whether it is healing or not. It started bleeding when I removed the bandage this morning.
Systemic reaction (other): Lesion next to the injection site is still open and oozing serous fluid. Slowly healing.
Systemic reaction (other): Erosive lesion adjacent to injection site. Now crusted, itching and healing.
Release 11 — 12 months, dose 2
Symptoms: COVID-19 infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site haemorrhage | ✓ | ✓ | ○ |
| SRO | Injection site infection | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Scab | ✓ | ✓ | ✓ |
| SRO | Skin haemorrhage | · | · | ✓ |
| SRO | Skin lesion | ✓ | ✓ | ✓ |
| SRO | Skin ulcer | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release